An increase in the half-life of remdesivir for COVID-19 treatment – News-Medical.net

The rapid outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) resulted in the coronavirus disease 2019 (COVID-19) pandemic and, to date, it has claimed more than 5.16 million lives worldwide.
Study: Nanoviricide’s platform technology…

Click here to view the original article.